Yuayan, Lynedee Mae C.
HRN: 04-89-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/15/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/15/2023
11/21/2023
IV
500mg
TID
AGE With Mod Dehydration
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes